ProQR Therapeutics (PRQR) Share-based Compensation (2013 - 2026)
ProQR Therapeutics' Share-based Compensation was $1.58 million in the quarter ended Jun 30, 2026, up 53.4% from $1.03 million a year earlier but down 5.6% from the prior quarter.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Share-based Compensation (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, ProQR Therapeutics' Share-based Compensation was $5.99 million through Jun 30, 2026, up 92.8% year-over-year; for the year ended Dec 31, 2025, it was $4.54 million, up 64.7% from the prior year.
- Share-based Compensation shows a five-year compound annual growth rate of -12.7% (years ended Dec 2020 to Dec 2025).
- In earlier years, Share-based Compensation was $2.75 million in the year ended Dec 31, 2024 (-18.0%), $3.36 million in the year ended Dec 31, 2023 (+11.1%), $3.02 million in the year ended Dec 31, 2022 (-58.9%) and $7.36 million in the year ended Dec 31, 2021 (-17.8%).
- Quarterly Share-based Compensation has moved between -$394,836 (the quarter ended Dec 31, 2022) and $2.04 million (the quarter ended Dec 31, 2021) over five years.
- Compared with a year earlier, Share-based Compensation has increased for five straight quarters, with growth averaging 56.8% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was the quarter ended Dec 31, 2025 (growth of 135.9%); the worst was the quarter ended Sep 30, 2023 (a decline of 64.1%).
- Per Business Quant data, PRQR's Share-based Compensation in the three quarters before the quarter ended Jun 30, 2026 was $1.67 million (quarter ended Mar 31, 2026), $1.43 million (quarter ended Dec 31, 2025) and $1.31 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | ProQR Therapeutics | 173.85 Mn | -289.75 Mn | - | 1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 797,328.41 |
| Dec 31, 2024 | 606,962.19 |
| Sep 30, 2024 | 672,110.34 |
| Jun 30, 2024 | 676,285.40 |
| Mar 31, 2024 | 799,562.26 |
| Dec 31, 2023 | 862,903.81 |
| Sep 30, 2023 | 483,334.17 |
| Jun 30, 2023 | 833,027.16 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | -394,835.73 |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 787,487.84 |
| Mar 31, 2022 | 1.33 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 2.02 Mn |
API Access
ProQR Therapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();